Can New Pain Drugs Break Through To A Growing Cancer Market and Beyond?
By
Paul Bonanos, John Davis / Email the Authors / “The Pink Sheet” Jul. 11, 2011, Vol. 73, No. 28
Business & Finance / Word Count: 1329 / Article # 00110711019
Executive Summary
Two new drug approvals represent the latest innovations in the emerging area of breakthrough cancer pain, designed to ease intense, short-term waves of heightened suffering in patients who are already taking opioids for persistent background pain.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.